University Medical Center of the Johannes-Gutenberg University, Department of Oral and Maxillofacial Surgery, Mainz, Germany.
Clin Implant Dent Relat Res. 2012 Mar;14(1):127-34. doi: 10.1111/j.1708-8208.2009.00237.x. Epub 2010 Feb 11.
Long-term results in the clinical outcome of different implant systems, including high patient numbers and a long follow-up time, are rare. This retrospective study evaluated the cumulative survival rate of a self-tapping, cylindrical implant system with a conical implant-abutment connection after 10 years of prosthetic loading.
A total of 516 TiOblast implants (Astra Tech AB, Mölndal, Sweden) were placed in 108 patients. The patients were treated in the Department of Oral and Maxillofacial Surgery, Johannes Gutenberg University, Mainz, Germany, between September 1994 and May 2005. The main indications for implantation were the treatment of edentulous mandibles (74%) and partial edentulism (15%). Twenty-three implants were placed postradiation, and a further 64 implants were irradiated after insertion. In 153 implants, a bony augmentation was conducted prior to implantation.
The in situ rate was 89.7% after an average implantation time of 108 months. Eighty-three patients with 403 implants were available for investigation. Seventeen patients with 76 implants have died since 1994. Absence of osseointegration (n = 22), peri-implantitis (n = 18), fracture of the implants (n = 9), failing of primary stability (n = 2), and implants next to tumors (n = 2) were the reasons of explantation in 26 patients. Under analysis with different implant success-assessment criteria, the success rate showed results from 76 to 89%.
With respect to the critical patient selection including a high number of patients with minor and major augmentations, the 10-year clinical use of the studied implant system showed acceptable results.
不同种植体系统的临床结果的长期结果(包括大量患者和长期随访时间)很少见。本回顾性研究评估了一种自攻式、圆柱形种植体系统在经过 10 年修复负荷后,具有锥形种植体-基台连接的累积存活率。
共放置了 516 个 TiOblast 种植体(AstraTech AB,Mölndal,瑞典)在 108 名患者中。患者在德国美因茨约翰内斯古滕贝格大学口腔颌面外科接受治疗,时间为 1994 年 9 月至 2005 年 5 月。植入的主要适应症是治疗无牙下颌(74%)和部分无牙(15%)。23 个种植体在放疗后放置,另有 64 个种植体在插入后进行放疗。在 153 个种植体中,在植入前进行了骨增量。
在平均植入时间 108 个月后,原位率为 89.7%。83 名患者中有 403 个种植体可供研究。自 1994 年以来,17 名患者中有 76 个种植体死亡。26 名患者中有 22 名种植体未发生骨整合(n=22)、种植体周围炎(n=18)、种植体骨折(n=9)、初级稳定性丧失(n=2)和紧邻肿瘤的种植体(n=2)是导致种植体拔除的原因。在使用不同的种植体成功评估标准进行分析时,成功率从 76%到 89%不等。
考虑到包括大量进行小和大增量的患者的临界患者选择,研究中使用的种植体系统的 10 年临床应用结果是可以接受的。